Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5*

The oncoprotein MDM2 associates with ribosomal proteins L5, L11, and L23. Both L11 and L23 have been shown to activate p53 by inhibiting MDM2-mediated p53 suppression. Here we have shown that L5 also activates p53. Overexpression of L5 stabilized ectopic p53 in H1299 cells and endogenous p53 in U2OS cells. Consequently, L5 enhanced p53 transcriptional activity and induced p53-dependent G1 cell cycle arrest. Furthermore, like L11 and L23, L5 also remarkably inhibited MDM2-mediated p53 ubiquitination. The interaction of L5 with MDM2 was also enhanced by treatment with a low dose of actinomycin D. Actinomycin D-induced p53 was inhibited by small interference RNA against L5. By reciprocal co-immunoprecipitation, we further showed that there were at least two MDM2-ribosomal protein complexes in cells: MDM2-L5-L11-L23 and p53-MDM2-L5-L11-L23. We propose that the MDM2-L5-L11-L23 complex functions to inhibit MDM2-mediated p53 ubiquitination and thus activates p53.

[1]  M. Dai,et al.  Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition , 2004, Molecular and Cellular Biology.

[2]  S. Karlsson,et al.  Targeted Disruption of the Ribosomal Protein S19 Gene Is Lethal Prior to Implantation , 2004, Molecular and Cellular Biology.

[3]  T. Allio,et al.  Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway , 2003, Molecular and Cellular Biology.

[4]  M. Dai,et al.  MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation , 2003, The EMBO journal.

[5]  H. Kawai,et al.  Critical Contribution of the MDM2 Acidic Domain to p53 Ubiquitination , 2003, Molecular and Cellular Biology.

[6]  Petra de Graaf,et al.  Critical Role for a Central Part of Mdm2 in the Ubiquitylation of p53 , 2003, Molecular and Cellular Biology.

[7]  M. Kubbutat,et al.  Regulation of HDM2 activity by the ribosomal protein L11. , 2003, Cancer cell.

[8]  Wei Gu,et al.  Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. , 2003, Current opinion in cell biology.

[9]  J. Qin,et al.  Parc A Cytoplasmic Anchor for p53 , 2003, Cell.

[10]  M. Oren,et al.  Regulation of p53 , 2002, Annals of the New York Academy of Sciences.

[11]  M. Dai,et al.  SSRP1 functions as a co‐activator of the transcriptional activator p63 , 2002, The EMBO journal.

[12]  M. Dai,et al.  MDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation* , 2002, The Journal of Biological Chemistry.

[13]  Z. Strezoska,et al.  Functional Inactivation of the Mouse Nucleolar Protein Bop1 Inhibits Multiple Steps in Pre-rRNA Processing and Blocks Cell Cycle Progression* , 2002, The Journal of Biological Chemistry.

[14]  Lester F. Lau,et al.  Evidence of p53-Dependent Cross-Talk between Ribosome Biogenesis and the Cell Cycle: Effects of Nucleolar Protein Bop1 on G1/S Transition , 2001, Molecular and Cellular Biology.

[15]  Y. Xiong,et al.  Control of p53 ubiquitination and nuclear export by MDM2 and ARF. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  D. Haines,et al.  A Novel Cellular Protein (MTBP) Binds to MDM2 and Induces a G1 Arrest That Is Suppressed by MDM2* , 2000, The Journal of Biological Chemistry.

[17]  K. Vousden,et al.  Stress Signals Utilize Multiple Pathways To Stabilize p53 , 2000, Molecular and Cellular Biology.

[18]  J. Hauber,et al.  Human Ribosomal Protein L5 Contains Defined Nuclear Localization and Export Signals* , 2000, The Journal of Biological Chemistry.

[19]  Shengyun Fang,et al.  Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53* , 2000, The Journal of Biological Chemistry.

[20]  T. Pieler,et al.  Functional Modules in Ribosomal Protein L5 for Ribonucleoprotein Complex Formation and Nucleocytoplasmic Transport* , 1999, The Journal of Biological Chemistry.

[21]  M. Kubbutat,et al.  Regulation of p53 Function and Stability by Phosphorylation , 1999, Molecular and Cellular Biology.

[22]  J. Hauber,et al.  Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Hirofumi Tanaka,et al.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 , 1997, FEBS letters.

[24]  J. Piette,et al.  Mdm2: keeping p53 under control , 1997, Oncogene.

[25]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[26]  A. Levine,et al.  The MDM2 Oncoprotein Binds Specifically to RNA through its RING Finger Domain , 1996, Molecular medicine.

[27]  Utz Fischer,et al.  The HIV-1 Rev Activation Domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs , 1995, Cell.

[28]  A. Levine,et al.  The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes , 1994, Molecular and cellular biology.

[29]  A. Levine,et al.  The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.

[30]  A. Levine,et al.  Mapping of the p53 and mdm-2 interaction domains. , 1993, Molecular and cellular biology.

[31]  Bert Vogelstein,et al.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.